0000899243-21-012738.txt : 20210319
0000899243-21-012738.hdr.sgml : 20210319
20210319161011
ACCESSION NUMBER: 0000899243-21-012738
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210319
DATE AS OF CHANGE: 20210319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thompson Alexis A.
CENTRAL INDEX KEY: 0001851895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 21758262
MAIL ADDRESS:
STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC.
STREET 2: 181 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER NAME:
FORMER CONFORMED NAME: Thompson Alexis
DATE OF NAME CHANGE: 20210317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-17
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001851895
Thompson Alexis A.
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
44.28
2021-03-17
4
A
0
11200
0.00
A
2031-03-16
Common Stock
11200
11200
D
Restricted Stock Units
2021-03-17
4
A
0
7200
0.00
A
Common Stock
7200
7200
D
The shares of Common Stock underlying the option vest in 36 equal monthly installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. This option is subject to accelerated vesting upon a change of control of the Issuer.
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon a change of control of the Issuer.
/s/ Tricia Suvari, Attorney-in-Fact
2021-03-19